ResearcherNorth Dakota State UniversityNo recent work listed
Harsharan Dhillon
Matched on OpenAlex author ID A5012835214. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper
Papers 3
- Piperlongumine potentiates the effects of gemcitabine in in vitro and in vivo human pancreatic cancer models. First author DOI 10.18632/oncotarget.23623↗
- Transcriptome Analysis of Piperlongumine-Treated Human Pancreatic Cancer Cells Reveals Involvement of Oxidative Stress and Endoplasmic Reticulum Stress Pathway… Co-author DOI 10.1089/jmf.2015.0152↗
- Piperlongumine induces pancreatic cancer cell death by enhancing reactive oxygen species and DNA damage. Co-author DOI 10.1016/j.toxrep.2014.05.011↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Katie M. Reindl · 3 shared papers, 2014–2018 · strength 0.24
- Paper Transcriptome Analysis of Piperlongumine-Treated Human Pancreatic Cancer Cells Reveals Involvement of Oxidative Stress … DOI 10.1089/jmf.2015.0152↗
- Paper Piperlongumine potentiates the effects of gemcitabine in in vitro and in vivo human pancreatic cancer models. DOI 10.18632/oncotarget.23623↗
- Paper Piperlongumine induces pancreatic cancer cell death by enhancing reactive oxygen species and DNA damage. DOI 10.1016/j.toxrep.2014.05.011↗
- Megan Orr · 1 shared paper, 2018 · strength 0.08
- John Curlee Wilkinson · 1 shared paper, 2018 · strength 0.08
- Jiyan Mohammad · 1 shared paper, 2018 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.